Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis

BackgroundThe complement system is locally activated after joint injuries and leads to the deposition of the terminal complement complex (TCC). Sublytic TCC deposition is associated with phenotypical alterations of human articular chondrocytes (hAC) and enhanced release of inflammatory cytokines. Ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Leonie Ruths, Jana Hengge, Graciosa Q. Teixeira, Melanie Haffner-Luntzer, Anita Ignatius, Jana Riegger
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1470907/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841540095337824256
author Leonie Ruths
Jana Hengge
Graciosa Q. Teixeira
Melanie Haffner-Luntzer
Anita Ignatius
Jana Riegger
author_facet Leonie Ruths
Jana Hengge
Graciosa Q. Teixeira
Melanie Haffner-Luntzer
Anita Ignatius
Jana Riegger
author_sort Leonie Ruths
collection DOAJ
description BackgroundThe complement system is locally activated after joint injuries and leads to the deposition of the terminal complement complex (TCC). Sublytic TCC deposition is associated with phenotypical alterations of human articular chondrocytes (hAC) and enhanced release of inflammatory cytokines. Chronic inflammation is a known driver of chondrosenescence in osteoarthritis (OA). Therefore, we investigated whether TCC deposition contributes to stress-induced premature senescence (SIPS) during aging in vivo and after ex vivo cartilage injury.MethodsFemoral condyles of male 13-week-old and 72-week-old CD59-ko (higher TCC deposition), C6-deficient (insufficient TCC formation), and C57BL/6 (WT) mice were collected to assess age-related OA. Furthermore, macroscopically intact human and porcine cartilage explants were traumatized and cultured with/without 30% human serum (HS) to activate the complement system. Explants were additionally treated with clusterin (CLU, TCC inhibitor), N-acetylcysteine (NAC, antioxidant), Sarilumab (IL-6 receptor inhibitor), STAT3-IN-1 (STAT3 inhibitor), or IL-1 receptor antagonist (IL-1RA) in order to investigate the consequences of TCC deposition. Gene and protein expression of senescence-associated markers such as CDKN1A and CDKN2A was determined.ResultsIn the murine aging model, CD59-ko mice developed after 72 weeks more severe OA compared to C6-deficient and WT mice. mRNA analysis revealed that the expression of Cdkn1a, Cdkn2a, Tp53, Il1b, and Il6 was significantly increased in the cartilage of CD59-ko mice. In human cartilage, trauma and subsequent stimulation with HS increased mRNA levels of CDKN1A, CDKN2A, and IL6, while inhibition of TCC formation by CLU reduced the expression. Antioxidative therapy with NAC had no anti-senescent effect. In porcine tissue, HS exposure and trauma had additive effects on the number of CDKN2A-positive cells, while Sarilumab, STAT-IN-1, and IL-1RA reduced CDKN2A expression by trend.ConclusionOur results demonstrate that complement activation and consequent TCC deposition is associated with chondrosenescence in age-related and trauma-induced OA. We provided evidence that the SIPS-like phenotype is more likely induced by TCC-mediated cytokine release rather than oxidative stress. Overall, targeting TCC formation could be a future approach to attenuate OA progression.
format Article
id doaj-art-2440fc7e2d6e49a69e7392dda7ef88ed
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-2440fc7e2d6e49a69e7392dda7ef88ed2025-01-14T06:10:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.14709071470907Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritisLeonie Ruths0Jana Hengge1Graciosa Q. Teixeira2Melanie Haffner-Luntzer3Anita Ignatius4Jana Riegger5Division for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, Ulm University Medical Center, Ulm, GermanyDivision for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, Ulm University Medical Center, Ulm, GermanyInstitute of Orthopedic Research and Biomechanics, Ulm University Medical Center, Ulm, GermanyInstitute of Orthopedic Research and Biomechanics, Ulm University Medical Center, Ulm, GermanyInstitute of Orthopedic Research and Biomechanics, Ulm University Medical Center, Ulm, GermanyDivision for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, Ulm University Medical Center, Ulm, GermanyBackgroundThe complement system is locally activated after joint injuries and leads to the deposition of the terminal complement complex (TCC). Sublytic TCC deposition is associated with phenotypical alterations of human articular chondrocytes (hAC) and enhanced release of inflammatory cytokines. Chronic inflammation is a known driver of chondrosenescence in osteoarthritis (OA). Therefore, we investigated whether TCC deposition contributes to stress-induced premature senescence (SIPS) during aging in vivo and after ex vivo cartilage injury.MethodsFemoral condyles of male 13-week-old and 72-week-old CD59-ko (higher TCC deposition), C6-deficient (insufficient TCC formation), and C57BL/6 (WT) mice were collected to assess age-related OA. Furthermore, macroscopically intact human and porcine cartilage explants were traumatized and cultured with/without 30% human serum (HS) to activate the complement system. Explants were additionally treated with clusterin (CLU, TCC inhibitor), N-acetylcysteine (NAC, antioxidant), Sarilumab (IL-6 receptor inhibitor), STAT3-IN-1 (STAT3 inhibitor), or IL-1 receptor antagonist (IL-1RA) in order to investigate the consequences of TCC deposition. Gene and protein expression of senescence-associated markers such as CDKN1A and CDKN2A was determined.ResultsIn the murine aging model, CD59-ko mice developed after 72 weeks more severe OA compared to C6-deficient and WT mice. mRNA analysis revealed that the expression of Cdkn1a, Cdkn2a, Tp53, Il1b, and Il6 was significantly increased in the cartilage of CD59-ko mice. In human cartilage, trauma and subsequent stimulation with HS increased mRNA levels of CDKN1A, CDKN2A, and IL6, while inhibition of TCC formation by CLU reduced the expression. Antioxidative therapy with NAC had no anti-senescent effect. In porcine tissue, HS exposure and trauma had additive effects on the number of CDKN2A-positive cells, while Sarilumab, STAT-IN-1, and IL-1RA reduced CDKN2A expression by trend.ConclusionOur results demonstrate that complement activation and consequent TCC deposition is associated with chondrosenescence in age-related and trauma-induced OA. We provided evidence that the SIPS-like phenotype is more likely induced by TCC-mediated cytokine release rather than oxidative stress. Overall, targeting TCC formation could be a future approach to attenuate OA progression.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1470907/fullosteoarthritiscomplement systemterminal complement complexsenescenceinterleukin-6
spellingShingle Leonie Ruths
Jana Hengge
Graciosa Q. Teixeira
Melanie Haffner-Luntzer
Anita Ignatius
Jana Riegger
Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
Frontiers in Immunology
osteoarthritis
complement system
terminal complement complex
senescence
interleukin-6
title Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
title_full Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
title_fullStr Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
title_full_unstemmed Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
title_short Terminal complement complex deposition on chondrocytes promotes premature senescence in age- and trauma-related osteoarthritis
title_sort terminal complement complex deposition on chondrocytes promotes premature senescence in age and trauma related osteoarthritis
topic osteoarthritis
complement system
terminal complement complex
senescence
interleukin-6
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1470907/full
work_keys_str_mv AT leonieruths terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis
AT janahengge terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis
AT graciosaqteixeira terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis
AT melaniehaffnerluntzer terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis
AT anitaignatius terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis
AT janariegger terminalcomplementcomplexdepositiononchondrocytespromotesprematuresenescenceinageandtraumarelatedosteoarthritis